Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma

(MedPage Today) -- Adding immunotherapy to neoadjuvant chemotherapy for resectable gastroesophageal cancer led to higher rates of disease downstaging and pathologic complete response (pCR), an exploratory analysis of a randomized trial showed...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news